6-85508042-TA-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_153816.6(SNX14):c.2670del(p.Cys890Ter) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,612,764 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000043 ( 0 hom. )
Consequence
SNX14
NM_153816.6 frameshift
NM_153816.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.942
Genes affected
SNX14 (HGNC:14977): (sorting nexin 14) This gene encodes a member of the sorting nexin family. Members of this family have a phox (PX) phosphoinositide binding domain and are involved in intracellular trafficking. The encoded protein also contains a regulator of G protein signaling (RGS) domain. Regulator of G protein signaling family members are regulatory molecules that act as GTPase activating proteins for G alpha subunits of heterotrimeric G proteins. Alternate splicing results in transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-85508042-TA-T is Pathogenic according to our data. Variant chr6-85508042-TA-T is described in ClinVar as [Pathogenic]. Clinvar id is 190320.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SNX14 | NM_153816.6 | c.2670del | p.Cys890Ter | frameshift_variant | 27/29 | ENST00000314673.8 | NP_722523.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SNX14 | ENST00000314673.8 | c.2670del | p.Cys890Ter | frameshift_variant | 27/29 | 1 | NM_153816.6 | ENSP00000313121 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152160Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
2
AN:
152160
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000639 AC: 16AN: 250206Hom.: 0 AF XY: 0.0000518 AC XY: 7AN XY: 135244
GnomAD3 exomes
AF:
AC:
16
AN:
250206
Hom.:
AF XY:
AC XY:
7
AN XY:
135244
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000431 AC: 63AN: 1460604Hom.: 0 Cov.: 30 AF XY: 0.0000468 AC XY: 34AN XY: 726594
GnomAD4 exome
AF:
AC:
63
AN:
1460604
Hom.:
Cov.:
30
AF XY:
AC XY:
34
AN XY:
726594
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152160Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74350
GnomAD4 genome
AF:
AC:
2
AN:
152160
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 27, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25848753, 34426522) - |
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | Mar 08, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2020 | - - |
Autosomal recessive spinocerebellar ataxia 20 Pathogenic:3
Pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | May 02, 2023 | The homozygous p.Lys889_Cys890insTer variant in SNX14 was identified by our study in one individual with spinocerebellar ataxia. The p.Lys889_Cys890insTer variant in SNX14 has been previously reported in 4 affected relatives from one family with autosomal recessive spinocerebellar ataxia 20 (PMID: 25848753) but has been identified in 0.01% (17/128632) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs774694340). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. These 4 affected individuals were homozygotes (PMID: 25848753), and the individual identified by our study was also a homozygote, which increases the likelihood that the p.Lys889_Cys890insTer variant is pathogenic. This variant has also been reported in ClinVar (Variation ID: 190320) and has been interpreted as pathogenic by OMIM, GeneDx, HudsonAlpha Institute for Biotechnology, and CeGaT Center for Human Genetics Tuebingen. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 889 and leads to a premature termination codon 1 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the SNX14 gene is an established disease mechanism in autosomal recessive spinocerebellar ataxia 20. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive spinocerebellar ataxia 20. ACMG/AMP Criteria applied: PVS1, PM2_Supporting, PM3, PP1_Moderate (Richards 2015). - |
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2015 | - - |
Pathogenic, criteria provided, single submitter | research | HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology | Jan 12, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at